Clinical Trials
3 trialsNCT01100619 2013-09-19
A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
Exelixis
Phase 1 Completed
NCT00084578 2013-07-15
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
Fox Chase Cancer Center
Phase NA Withdrawn
NCT00182052 2013-05-23
Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer
Massachusetts General Hospital
Phase 3 Completed